Aeglea BioTherapeutics
cash and anticipated milestones | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2023
Slide
34 of 37
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
October 2023
cash and anticipated milestones | Aeglea BioTherapeutics
Related slides by other companies
Anebulo Pharmaceuticals
Investor Day
September 2022
phase part a and part interim data of | Anebulo Pharmaceuticals
Anebulo Pharmaceuticals
Investor Day
September 2022
phase part a and part interim data of in plasma | Anebulo Pharmaceuticals
Electronic Arts
Results
August 2022
cash flow selected data investing cash flow financing cash flow operating cash flow capital expenditures a free cash flow a | Electronic Arts
Erasca
Investor Presentation
November 2023
phase data showed is preferable to dosing simulations suggest bid dosing may improve profiles and even more | Erasca
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights